Bone mineral density and vitamin D in PCOS and hirsutism

被引:16
作者
Glintborg, Dorte [1 ]
Hermann, Anne Pernille [1 ]
Andersen, Marianne [1 ]
机构
[1] Odense Univ Hosp, Dept Endocrinol, Sdr Blvd 29, DK-5000 Odense C, Denmark
关键词
BMD; insulin; metformin; testosterone; vitamin D;
D O I
10.1586/17446651.2013.827384
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is the most frequent endocrinopathy in reproductive-aged women. The majority of hirsute patients are diagnosed with PCOS. Hyperandrogenemia, central obesity and insulin resistance may protect patients with PCOS from osteoporosis, whereas increased cortisol levels, low growth hormone and amenorrhea may be associated with decreased bone mineral density (BMD). Recent studies suggested that insulin resistance in PCOS is associated with decreased vitamin D levels that could not be explained by obesity alone. Vitamin D treatment may therefore have positive effects on insulin sensitivity and perhaps also hyperandrogenemia in patients with PCOS. In the present article, we review the evidence of changed BMD, bone mineral turnover and vitamin D status in PCOS and hirsutism compared with healthy women and the effects of medical intervention on BMD in PCOS.
引用
收藏
页码:449 / 459
页数:11
相关论文
共 100 条
  • [81] Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction
    Pepene, Carmen Emanuela
    Ilie, Ioana Rada
    Marian, Ioan
    Duncea, Ileana
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (01) : 61 - 68
  • [82] BONE-MINERAL DENSITY IN HYPERANDROGENIC AMENORRHEA
    PREZELJ, J
    KOCIJANCIC, A
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1993, 52 (06) : 422 - 424
  • [83] Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency
    Rahimi-Ardabili, H.
    Gargari, B. Pourghassem
    Farzadi, L.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2013, 36 (01) : 28 - 32
  • [84] Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women
    Rapuri, PB
    Kinyamu, HK
    Gallagher, JC
    Haynatzka, V
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) : 2024 - 2032
  • [85] THE EFFECTS OF CALCIUM-VITAMIN D AND METFORMIN ON POLYCYSTIC OVARY SYNDROME: A PILOT STUDY
    Rashidi, Batool
    Haghollahi, Fedieh
    Shariat, Mamak
    Zayerii, Farid
    [J]. TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2009, 48 (02): : 142 - 147
  • [86] Ravn P, 2013, MINERVA ENDOCRINOL, V38, P59
  • [87] Bone Effects of Glitazones and Other Anti-Diabetic Drugs
    Rejnmark, Lars
    [J]. CURRENT DRUG SAFETY, 2008, 3 (03) : 194 - 198
  • [88] Aromatase in human bone tissue
    Sasano, H
    Uzuki, M
    Sawai, T
    Nagura, H
    Matsunaga, G
    Kashimoto, O
    Harada, N
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (09) : 1416 - 1423
  • [89] Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome - a long-term follow-up study
    Schmidt, Johanna
    Dahlgren, Eva
    Brannstrom, Mats
    Landin-Wilhelmsen, Kerstin
    [J]. CLINICAL ENDOCRINOLOGY, 2012, 77 (02) : 207 - 214
  • [90] Scragg R, DIABETES RES CLIN PR, V27